Pharmacokinetics of indinavir in HIV-infected children

被引：0
|
作者：
Burger, DM
Hugen, PWH
de Groot, R
机构：
[1] Univ Nijmegen Hosp, Dept Clin Pharm, NL-6500 HB Nijmegen, Netherlands
[2] Sophia Childrens Hosp, Dept Pediat Dis, NL-3015 GJ Rotterdam, Netherlands
来源：
AIDS | 1998年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P304
引用
收藏
页码：S93 / S93
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics of indinavir in HIV-infected children
    Burger, DM
    Hugen, PWH
    de Groot, R
    [J]. AIDS, 1998, 12 : S10 - S10
  • [2] Effect of indinavir on the pharmacokinetics of rifampicin in HIV-infected patients
    Jaruratanasirikul, S
    Sriwiriyajan, S
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (03) : 409 - 412
  • [3] Intracellular indinavir pharmacokinetics in HIV-infected patients: comparison with plasma pharmacokinetics
    Hennessy, M
    Clarke, S
    Spiers, JP
    Mulcahy, F
    Kelleher, D
    Megdon, E
    Maher, B
    Bergin, C
    Khoo, S
    Tjia, J
    Hoggard, P
    Back, D
    Barry, M
    [J]. ANTIVIRAL THERAPY, 2003, 8 (03) : 191 - 198
  • [4] Indinavir pharmacokinetics during different phases of the menstrual cycle in HIV-infected women
    Frost, CE
    Adams, J
    Shelton, M
    Ebid, AHIM
    Gugino, LJ
    Hewitt, R
    DiFrancesco, R
    Ingalls, E
    Cousins, S
    Hu, J
    Morse, GD
    [J]. CLINICAL DRUG INVESTIGATION, 2002, 22 (02) : 125 - 134
  • [5] Indinavir Pharmacokinetics during Different Phases of the Menstrual Cycle in HIV-Infected Women
    Charles E. Frost
    John Adams
    Mark Shelton
    Abdel-Hameed I. Mohammed Ebid
    Lawrence J. Gugino
    Ross Hewitt
    Robin DiFrancesco
    Elizabeth Ingalls
    Stephen Cousins
    J. Hu
    Gene D. Morse
    [J]. Clinical Drug Investigation, 2002, 22 : 125 - 134
  • [6] Population Pharmacokinetics of Dapsone in HIV-Infected Children
    Mark Mirochnick
    Ellen Cooper
    Jing Xu
    Jane Lindsey
    Edmund Capparelli
    Ken McIntosh
    James McNamara
    Lynne M Mofenson
    David Jacobus
    [J]. Pediatric Research, 1999, 45 (7) : 168 - 168
  • [7] Population pharmacokinetics of dapsone in HIV-infected children
    Mirochnick, M
    Cooper, E
    Xu, J
    Lindsey, J
    Capparelli, E
    McIntosh, K
    McNamara, J
    Mofenson, LM
    Jacobus, D
    [J]. PEDIATRIC RESEARCH, 1999, 45 (04) : 168A - 168A
  • [8] Nephrolithiasis in HIV-infected patients treated with indinavir
    Rodriguez-Rosado, R
    Jimenez-Nacher, I
    Valencia, E
    Soriano, V
    Gonzalez-Lahoz, JG
    [J]. ANTIVIRAL THERAPY, 1998, 3 (02) : 113 - 113
  • [9] Pharmacokinetics and pharmacodynamics of indinavir with or without low-dose ritonavir in HIV-infected Thai patients
    Burger, D
    Boyd, M
    Duncombe, C
    Felderhof, M
    Mahanontharit, A
    Ruxrungtham, K
    Ubolyam, S
    Stek, M
    Cooper, D
    Lange, J
    Phanupak, P
    Reiss, P
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (05) : 1231 - 1238
  • [10] Pharmacokinetics of orally administered zidovudine in HIV-infected children and adults
    Wintergerst, U
    Rolinski, B
    VocksHauck, M
    Wahn, V
    Debatin, KM
    Notheis, G
    GroschWorner, I
    Goebel, FD
    Roscher, AA
    Belohradsky, BH
    [J]. INFECTION, 1995, 23 (06) : 344 - 348
12345